14 results for "Burr, Adam"
Showing 1–14 · 0.57 seconds · RSS
-
Journal Article Full text
Patterns of failure for hypopharynx cancer patients treated with limited high-dose radiotherapy treatment volumes
PURPOSE: Optimal radiotherapy treatment volumes for patients with locally advanced hypopharynx squamous cell carcinoma should ensure maximal tumor coverage with minimal inclusion of normal surrounding structures. Here we evaluated the effectiveness of a direct 3-mm high-dose gross tumor volume to…
-
Journal Article Full text
Review of recent advances in managing periocular skin malignancies
Management of cutaneous malignancies can be particularly challenging when they are located in the periocular region. The standard of care for localized disease is complete surgical excision, but this may not be possible without significant disruption to visual structures and facial appearance…
-
Journal Article Full text
Combining Obinutuzumab With Radiation for Refractory DLBCL: Retrospective Safety and Efficacy Analysis
PURPOSE: Approximately 30% of patients with diffuse large B cell lymphoma (DLBCL) will develop relapsed or treatment-refractory disease after primary chemotherapy. Patients unable to undergo aggressive chemotherapy and stem cell transplant or chimeric antigen receptor T-cell (CAR T-cell) therapy…
-
Journal Article Full text
RADT-25. RECURRENT MENINGIOMAS REIRRADIATED WITH LARGE-VOLUME PULSED-REDUCED DOSE RATE RADIOTHERAPY: LONG-TERM SURVIVAL AND TOXICITY OUTCOMES
Meningiomas are the most common primary brain tumors in adults. Although local control is often achievable with surgical resection and radiation therapy, patients with recurrent disease treated with prior radiotherapy (RT) have few options for salvage treatment. We investigate retrospectively…
-
Journal Article Full text
CTNI-48. SURVIVAL, TOXICITY, AND PATIENT REPORTED QOL OUTCOMES FOLLOWING PULSED REDUCED DOSE RATE RE-IRRADIATION WITH CONCURRENT BEVACIZUMAB FOR RECURRENT GRADE 4 GLIOMAS: RESULTS OF A PHASE II STUDY
Grade 4 gliomas are aggressive primary brain tumors with dismal prognosis despite maximal treatment. Recurrent disease is typically found within the prior radiation treatment field, complicating reirradiation. Pulsed reduced dose rate (PRDR) radiation is a treatment technique that reduces effective…
-
Journal Article Full text
Evaluation of a Novel Quantitative Multiparametric MR Sequence for Radiation Therapy Treatment Response Assessment
BACKGROUND: Multi-parametric MRI has shown great promise to rapidly derive multiple quantitative imaging biomarkers for treatment response assessment. PURPOSE: To evaluate a novel Deep-Learning-enhanced MUlti-PArametric MR sequence (DL-MUPA) for treatment response assessment for brain metastases…
Also available at: PubMed Central
-
Journal Article Full text
Pulsed reduced-dose rate re-irradiation for patients with recurrent grade 2 gliomas
BACKGROUND: Patients with grade 2 glioma exhibit highly variable survival. Re-irradiation for recurrent disease has limited mature clinical data. We report treatment results of pulsed reduced-dose rate (PRDR) radiation for patients with recurrent grade 2 glioma. METHODS: A retrospective analysis of…
-
Journal Article Full text
Functional Outcomes After Transoral Plus Lateral Pharyngotomy Approach for Advanced Oral and Oropharyngeal Tumors
OBJECTIVE: The aim of this study was to evaluate our institutional experience with the combined transoral plus lateral pharyngotomy (TO+LP) approach in a subset of patients with advanced or recurrent oral and oropharyngeal malignancy. STUDY DESIGN: A retrospective study of procedures utilizing…
-
Journal Article Full text
Metrics of dose to highly ventilated lung are predictive of radiation-induced pneumonitis in lung cancer patients
PURPOSE: To identify metrics of radiation dose delivered to highly ventilated lung that are predictive of radiation-induced pneumonitis. METHODS AND MATERIALS: A cohort of 90 patients with locally advanced non-small cell lung cancer treated with standard fractionated radiation therapy (RT) (60-66…
-
Journal Article Full text
Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction (MARSH): A pilot, first-in-human study of interferon gamma-stimulated marrow mesenchymal stromal cells for treatment of radiation-induced xerostomia
BACKGROUND AIMS: Xerostomia, or the feeling of dry mouth, is a significant side effect of radiation therapy for head and neck cancer (HNC). Preliminary data suggests that mesenchymal stromal/stem cells (MSCs) can improve salivary function. We performed a first-in-human pilot study of interferon…
-
Journal Article Full text
Prospective study of PET/MRI tumor response during chemoradiotherapy for patients with low and intermediate-risk p16-positive oropharynx cancer
OBJECTIVES: To examine tumor response with PET/MRI during chemoradiotherapy as a predictor of outcome in patients with p16-positive oropharynx cancer. METHODS: Patients with p16-positive oropharynx cancer were treated with chemoradiotherapy. Low-risk (LR) disease was defined as T1–3 and N0–2b and ≤…
-
Journal Article Full text
Interstitial Brachytherapy for Lip Cancer: Technical Aspects to Individualize Treatment Approach and Optimize Outcomes
Primary radiotherapy using interstitial brachytherapy (IBT) provides excellent local tumor control for early-stage squamous cell carcinoma (SCC) of the lip. Technical aspects of treatment are important to optimize outcomes. In this report, we discuss patient selection criteria, procedural details…
-
Journal Article Full text
Safety and toxicity of Iopofosine I 131 (CLR 131) with external beam radiation therapy in recurrent or metastatic head and neck cancer: results of a phase 1 single-centre, open-label, single-arm, dose escalation and dose expansion study
BACKGROUND: Re-irradiation of recurrent head and neck cancer (HNC) is often limited by tumour adherence to critical structures and/or radiation tolerance of critical normal tissues. Iopofosine I 131 (CLR 131) is a targeted small molecular phospholipid ether (PLE) drug conjugate that delivers…